TapewireFind a company

person · Reporting owner

Stokes Frank

Disclosed activity across 2 companies

Tapewire entity
22194
SEC CIK
0001782815

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CASTLE BIOSCIENCES INCCSTL · Entity 359Chief Financial OfficerAugust 14, 2026August 18, 2026
EXAGEN INC.XGN · Entity 935DirectorJune 09, 2026June 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CASTLE BIOSCIENCES INC

Report date August 14, 2026 · Filed August 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect35,177 Reported balance After 2026-08-14 transaction · row 1
1 source row

Row 1 · 2026-08-14 · Sale · Disposed 24,908 · Balance 35,177

F1: This transaction was executed in multiple trades at prices ranging from $29.71 to $29.97, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $29.71 to $29.97, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

EXAGEN INC.

Report date June 09, 2026 · Filed June 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option(right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.31 · Expires 2036-06-08Direct112,500 Reported balance After 2026-06-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-09 · Grant · Acquired 37,500 · Balance 112,500

F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 10, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · derivative · entry 9

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 8,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 8,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,170 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · derivative · entry 8

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,339

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

F3 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 584 $20.17 $11,779.28
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · nonDerivative · entry 6

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,551

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · nonDerivative · entry 5

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,135

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 1,802 $20.17 $36,346.34
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · nonDerivative · entry 4

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,135

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,170 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · nonDerivative · entry 3

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,937

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 09, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 14,617 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · derivative · entry 7

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,850

Underlying: Common Stock · 14,617 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 58,467 RSUs, which vest in four equal annual installments beginning on December 9, 2023

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 58,467 RSUs, which vest in four equal annual installments beginning on December 9, 2023

Read SEC document
December 09, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 4,269 $20.17 $86,105.73
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · nonDerivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,767

Read SEC document
December 09, 2023 Filed Dec 13, 2023 00:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 14,617 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000177 · wk-form4_1702427603.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
June 09, 2023 Filed Jun 13, 2023 20:36 UTC EXAGEN INC. XGN · Entity 935 GrantStock Option(right to buy) · Derivative 9,000 $0.00 Strike: $3.13 $0.00
Disclosure

SEC source: 0001274737-23-000064 · wf-form4_168668859227831.xml · derivative · entry 1

Stokes Frank · CIK 0001782815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-06-08

F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 20:44 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 4,000 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001447362-23-000056 · wf-form4_168072746660347.xml · derivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,712

Underlying: Common Stock · 4,000 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 20:44 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 4,000 $3.38 $13,520.00
Disclosure

SEC source: 0001447362-23-000056 · wf-form4_168072746660347.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 880 shares acquired on February 28, 2023, under the Issuer's employee stock purchase plan.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,170 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · derivative · entry 7

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,509

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · derivative · entry 6

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 8,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F3 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 8,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 1,817 $22.32 $40,555.44
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · nonDerivative · entry 4

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,539

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,170 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · nonDerivative · entry 3

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,356

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 589 $22.32 $13,146.48
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · nonDerivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,186

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,775

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:42 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 58,467 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000196 · wf-form4_167096768885809.xml · derivative · entry 5

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,467

Underlying: Common Stock · 58,467 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on December 9, 2023.

F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on December 9, 2023.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 12:32 UTC EXAGEN INC. XGN · Entity 935 GrantStock Option(right to buy) · Derivative 9,000 $0.00 Strike: $5.25 $0.00
Disclosure

SEC source: 0001274737-22-000040 · wf-form4_165581472086924.xml · derivative · entry 1

Stokes Frank · CIK 0001782815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
May 12, 2022 Filed May 16, 2022 20:18 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 4,000 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001447362-22-000089 · wf-form4_165273230340927.xml · derivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,712

Underlying: Common Stock · 4,000 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the 28,712 shares originally subject to the option vested on March 13, 2020, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
May 12, 2022 Filed May 16, 2022 20:18 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 4,000 $3.38 $13,520.00
Disclosure

SEC source: 0001447362-22-000089 · wf-form4_165273230340927.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,775

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 23:41 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantCommon Stock 1,114 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-22-000072 · wf-form4_165118923180398.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,775

F1 · shares: The reporting person acquired 1,114 shares of common stock on April 26, 2022, as consideration for the Reporting Person's equity securities of AltheaDx, Inc. ("AltheaDx"), which Castle Biosciences, Inc. ("Castle Biosciences") acquired by merger on April 26, 2022 (the "Merger") pursuant to an Agreement and Plan of Merger agreement dated April 4, 2022 (the "Merger Agreement"). Of the 1,114 shares issued to the Reporting Person in the Merger, 94 shares are currently being held in escrow and are subject to forfeiture for a specified period following the Merger to satisfy indemnification claims arising of Castle Biosciences, if any.

F2 · shares: The Merger Agreement provides that the former securityholders of AltheaDx may receive additional consideration, payable 50% in cash and 50% in shares of common stock of Castle Biosciences, based on the achievement of certain commercial milestones with related dates or performance periods through December 31, 2024 (the "Milestone Payments"). The portion of the Milestone Payments payable in shares of common stock will be valued at the volume-weighted average price for the 20 trading days ending as of the applicable determination date. The number of shares issuable is subject to certain limitations set forth in the Merger Agreement. The Reporting Person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on April 26, 2022, the effective date of the merger.

F3 · price: The number of shares issuable was determined pursuant to a formula set forth in the Merger Agreement, which provided that, for the purpose of determining the number of shares issuable, the shares of Castle Biosciences common stock would be valued at $42.54, which represents the volume weighted average share price of the stock for the 20 trading days immediately preceding the date of the Merger Agreement.

F4 · balance_after: Includes 331 shares acquired on February 28, 2022, under the Issuer's employee stock purchase plan.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 01:01 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001447362-21-000272 · wf-form4_163953007296482.xml · derivative · entry 5

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 8,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F5 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 8,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 01:01 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 24,679 $0.00 $0.00
Disclosure

SEC source: 0001447362-21-000272 · wf-form4_163953007296482.xml · derivative · entry 4

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,679

Underlying: Common Stock · 24,679 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on December 10, 2022.

F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on December 10, 2022.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 01:01 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantStock option (right to buy) · Derivative 42,550 $0.00 Strike: $40.52 $0.00
Disclosure

SEC source: 0001447362-21-000272 · wf-form4_163953007296482.xml · derivative · entry 3

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,550

Underlying: Common Stock · 42,550 shares

Expires 2031-12-09

F3 · derivative.exercise_date: 25% of the shares shall vest on December 10, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 01:01 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 895 $40.52 $36,265.40
Disclosure

SEC source: 0001447362-21-000272 · wf-form4_163953007296482.xml · nonDerivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,330

Read SEC document
December 10, 2021 Filed Dec 15, 2021 01:01 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-21-000272 · wf-form4_163953007296482.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · balance_after: Includes 305 shares acquired on August 31, 2021, under the Issuer's employee stock purchase plan.

Read SEC document
June 17, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 1,273 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · derivative · entry 9

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,137

Underlying: Common Stock · 1,273 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

F5 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
June 17, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 1,273 $73.00 $92,929.00
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · nonDerivative · entry 6

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,920

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

Read SEC document
June 17, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 1,273 $2.39 $3,042.47
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · nonDerivative · entry 5

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 12:39 UTC EXAGEN INC. XGN · Entity 935 GrantStock Option(right to buy) · Derivative 15,000 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001274737-21-000077 · wf-form4_162427914687839.xml · derivative · entry 1

Stokes Frank · CIK 0001782815 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on July 17, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 2,127 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · derivative · entry 8

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,410

Underlying: Common Stock · 2,127 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

F5 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 2,127 $73.07 $155,419.89
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · nonDerivative · entry 4

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,920

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $73.00 to $73.33, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 2,127 $2.39 $5,083.53
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · nonDerivative · entry 3

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 11,600 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · derivative · entry 7

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,537

Underlying: Common Stock · 11,600 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

F5 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 11,600 $73.02 $847,032.00
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · nonDerivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,920

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $73.00 to $73.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 15, 2021 Filed Jun 17, 2021 21:36 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 11,600 $2.39 $27,724.00
Disclosure

SEC source: 0001447362-21-000148 · wf-form4_162396576996441.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021.

F2 · balance_after: Includes 2,034 shares acquired on February 26, 2021 under the Issuer's employee stock purchase plan.

Read SEC document
January 12, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 7,500 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · derivative · entry 10

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,137

Underlying: Common Stock · 7,500 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F8 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
January 12, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 1,100 $78.98 $86,882.40
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 8

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,886

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F7 · price: This transaction was executed in multiple trades at prices ranging from $78.850 to $79.155, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 12, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 4,900 $78.29 $383,625.90
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 7

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,986

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F6 · price: This transaction was executed in multiple trades at prices ranging from $77.770 to $78.730, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 12, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 1,500 $77.02 $115,536.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 6

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,886

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F5 · price: This transaction was executed in multiple trades at prices ranging from $76.625 to $77.310, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 12, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 7,500 $2.39 $17,925.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 5

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 7,500 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · derivative · entry 9

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,637

Underlying: Common Stock · 7,500 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F8 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 200 $79.26 $15,851.60
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 4

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,886

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F4 · price: This transaction was executed in multiple trades at prices ranging from $79.255 to $79.260, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 6,000 $78.17 $469,020.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 3

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,086

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $78.000 to $78.600, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 1,300 $77.35 $100,555.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,086

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $76.950 to $77.790, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 21:08 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 7,500 $2.39 $17,925.00
Disclosure

SEC source: 0001447362-21-000010 · wf-form4_161057206721913.xml · nonDerivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 6, 2020.

Read SEC document
December 10, 2020 Filed Dec 14, 2020 19:11 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001447362-20-000291 · wf-form4_160797306720087.xml · derivative · entry 2

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on December 10, 2021.

F3 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2020 Filed Dec 14, 2020 19:11 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantStock option (right to buy) · Derivative 31,000 $0.00 Strike: $59.16 $0.00
Disclosure

SEC source: 0001447362-20-000291 · wf-form4_160797306720087.xml · derivative · entry 1

Stokes Frank · CIK 0001782815 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,000

Underlying: Common Stock · 31,000 shares

Expires 2030-12-09

F1 · derivative.exercise_date: 25% of shares shall vest on December 10, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.